CYTOTHERAPEUTICS
CytoTherapeutics focuses on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. It intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries. CytoTherapeutics was founded by Randy Werneth in 2009. It is based in Potsdam, Brandenburg.
Current Employees Featured
Founder
More informations about "CytoTherapeutics"
Home Page: Cytotherapy
Established in 1992, ISCT is the global steward fostering cell and gene therapy translation to the clinic. With a network of leading clinicians, regulators, researchers, technologists and industry partners, ISCT members have a …See details»
Cytotherapeutics - Products, Competitors, Financials, Employees ...
Use the CB Insights Platform to explore Cytotherapeutics's full profile. Cytotherapeutics - Products, Competitors, Financials, Employees, Headquarters Locations Technology VendorsSee details»
Cytotherapy - LinkedIn
Cytotherapy | 1,395 followers on LinkedIn. The Official Journal of ISCT: International Society for Cell & Gene Therapy | 2021 Impact Factor: 6.196 Cytotherapy, the official journal of the ...See details»
Cellular Transplants, 20 Years Later: The Pharma Initiative
Jul 6, 2009 One of the most prominent of those resulting companies was CytoTherapeutics, Inc. (CTI; originally called Cellular Transplants, Inc.). ... The authors have no other relevant …See details»
CytoTherapeutics Sells Encapsulated Cell Technology to Neurotech
Jan 18, 2000 CytoTherapeutics Inc. (Sunnyvale, CA) has sold its Encapsulated Cell Technology (ECT) to Neurotech S.A. (Evry, France), in order to concentrate on its stem cell technology …See details»
CytoTherapeutics - Contacts, Employees, Board Members, …
Organization. CytoTherapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
CytoTherapeutics - Overview, News & Similar companies - ZoomInfo
Providence, Rhode Island-based CytoTherapeutics is a leader in the development of cell-based therapeutics. Is this data correct? Popular Searches CytoTherapeutics Inc cyto.com SIC Code …See details»
BioPharmaLink profile of CytoTherapeutics, Inc.,
CytoTherapeutics, Inc. CytoTherapeutics, Inc. is a leader in the development of novel cell therapies designed to treat human diseases. The Company is developing products based on …See details»
CytoTherapeutics Sets Up Modex In Switzerland
Jul 14, 1996 CytoTherapeutics Sets Up Modex In Switzerland 14 July 1996 US company CytoTherapeutics Inc has established a subsidiary in Switzerland, Modex Therapeutiques, …See details»
Deciphering the therapeutic stem cell strategies of large and …
The slow adoption of cytotherapeutics remains a vexing hurdle given clinical progress achieved to date with a variety of stem cell lineages. Big and midsize pharmaceutical companies as an …See details»
Cyto Therapeutics Pty Ltd. - Drug pipelines, Patents ... - Patsnap
Jan 23, 2025 Cyto Therapeutics Pty Ltd., which is a subsidiary of International Stem Cell Corp., is an Australian-based organization that specializes in offering clinical research services. …See details»
Investors & Media - cytoimmune
Apr 11, 2022 We are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to utilize the power …See details»
The Potential of Cytotherapeutics in Hematologic Reconstitution …
May 1, 2015 The successful commercialization of cytotherapeutics to efficiently manage GvHD will create a virtuous ‘halo’ effect for regenerative medicine. ... The author has no other …See details»
Seth Rudnick - Co-Founder @ Altesa - Crunchbase Person Profile
Organization Name . Investor Name . Lead Investor . Funding Round . Money Raised . Jun 14, 2009: VaxInnate . ... Additionally, Seth Rudnick has had 4 past jobs including CEO and …See details»
The potential of cytotherapeutics in hematologic reconstitution …
Hematopoietic stem cell transplantation (HSCT) is a life-saving treatment for inherited anemias, immunodeficiencies or hematologic malignancies. A major complication of allo-HSCT …See details»
Biotechnology and Cytotherapeutics: The Swiss Progenitor-Cell
Historically, primary human progenitor cells (e.g., WI-38 and MRC-5 diploid-cell sources) have been industrially applied in research and in manufacturing processes for vaccines and for …See details»
The Critical Role of Cell Homing in Cytotherapeutics and …
Sep 30, 2018 The Critical Role of Cell Homing in Cytotherapeutics and Regenerative Medicine. Xiao-Tao He, Xiao-Tao He. State Key Laboratory of Military Stomatology, School of …See details»
The Potential of Cytotherapeutics in Hematologic Reconstitution …
May 1, 2015 The Potential of Cytotherapeutics in Hematologic Reconstitution and in the Treatment and Prophylaxis of Graft-Versus-Host Disease. ... The author has no other relevant …See details»
The changing landscape of cancer cell therapies: clinical trials and ...
May 31, 2024 Ana Rosa Saez-Ibañez. Anna-Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA.See details»